Integrated analysis and validation of metabolism-related genes in lung transplantation-induced cold ischemia/ reperfusion injury

肺移植诱导的冷缺血/再灌注损伤中代谢相关基因的综合分析与验证

阅读:1

Abstract

BACKGROUND: Primary graft dysfunction (PGD) usually occurs within 72 hours after lung transplantation and is primarily caused by ischemia-reperfusion injury (IRI). Patients who develop PGD after lung transplantation tend to have a poor prognosis. However, effective clinical strategies to reduce the incidence of primary graft dysfunction remain limited. Therefore, a comprehensive understanding of the mechanisms underlying lung ischemia-reperfusion injury is essential for improving outcomes in lung transplant recipients. METHODS: In this study, we explored the differential expression of metabolism-related genes in lung transplantation induced IRI and identify its potential molecular mechanisms by bioinformatics analysis. Next, we used two machine learning algorithms and further screened for key genes in them. The outside dataset GSE8021 was used to validated the accuracy of the model established by metabolism-related genes machine learning genes. In addition, we observed the distribution and localization of metabolism-related machine learning genes in the single-cell dataset GSE220797 and analyzed the correlation between metabolism-related machine learning genes and immune cells by the CIBERSORT immune infiltration algorithm. Finally, we validated the nine metabolism-related machine learning genes by rat orthotopic left lung transplantation model and Real-Time Quantitative Polymerase Chain Reaction (RT-qPCR), we found that seven of these metabolism-related machine learning genes were consistent with the results of the bioinformatics analysis. RESULTS: We identified multiple metabolism-related genes machine learning genes (PDE4B, CDA, HMOX1, EHHADH, AMD1, GUCY1A1, GUCY1B1, UGCG, and FPGT). Significant changes were observed in some of these genes following ischemia-reperfusion. They represent important biomarkers in ischemia-reperfusion injury induced by lung transplantation and hold promise as therapeutic targets for mitigating lung ischemia-reperfusion injury and reducing the incidence of primary graft dysfunction.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。